An Update of Pathology Review from the PCPT Trial
Ian M. Thompson, Jr., M.D. |
| |
| |
| Disclosure: |
- Mission Pharmacal Company: Consultant/Advisor
National Cancer Institute: Investigator
AstraZeneca: Meeting Participant/Lecturer
|
| |
| The American Urological Association designates this educational activity for a maximum of 0.25 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| |
| Estimated Time to Complete This Activity: 8 minutes |
|
 |
|
